Fiche du document
2008
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1093/intimm/dxn066
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/18573812
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1460-2377
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_12415A079C402
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Thymus-dependent lymphocytes Thymus-derived cells T lymphocytes Thymus-dependent cells Melanocytic tumor Malignant melanomaCiter ce document
V. Voelter et al., « Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor. », Serveur académique Lausannois, ID : 10.1093/intimm/dxn066
Métriques
Partage / Export
Résumé
Melan-A specific CD8+ T cells are thought to play an important role against the development of melanoma. Their in vivo expansion is often observed with advanced disease. In recent years, low levels of Melan-A reactive CD8+ T cells have also been found in HLA-A2 healthy donors, but these cells harbor naive characteristics and are thought to be mostly cross-reactive for the Melan-A antigen. Here, we report on a large population of CD8+ T cells reactive for the Melan-A antigen, identified in one donor with no evidence of melanoma. Interestingly, this population is oligoclonal and displays a clear memory phenotype. However, a detailed study of these cells indicated that they are unlikely to be directly specific for melanoma, so that their in vivo expansion may have been driven by an exogenous antigen. Screening of a Melan-A cross-reactive peptide library suggested that these cells may be specific for an epitope derived from a Mycobacterium protein, which would provide a further example of CD8+ T cell cross-reactivity between a pathogen antigen and a tumor antigen. Finally, we discuss potential perspectives regarding the role of such cells in heterologous immunity, by influencing the balance between protective immunity and pathology, e.g. in the case of melanoma development.
